Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Dragon
|
| gptkbp:approvedBy |
gptkb:FDA
adults |
| gptkbp:ATCCode |
M03AX01
|
| gptkbp:brand |
gptkb:Myobloc
NeuroBloc |
| gptkbp:CASNumber |
93384-43-1
|
| gptkbp:chemicalClass |
gptkb:protein
|
| gptkbp:discoveredBy |
gptkb:Emile_van_Ermengem
|
| https://www.w3.org/2000/01/rdf-schema#label |
botulinum toxin B
|
| gptkbp:mechanismOfAction |
inhibits acetylcholine release
|
| gptkbp:molecularWeight |
~150 kDa
|
| gptkbp:notRecommendedFor |
children
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:producedBy |
gptkb:Clostridium_botulinum
|
| gptkbp:relatedTo |
botulinum toxin A
|
| gptkbp:riskFactor |
botulism
|
| gptkbp:routeOfAdministration |
intramuscular injection
|
| gptkbp:sideEffect |
injection site pain
dry mouth dysphagia |
| gptkbp:toxicity |
gptkb:Type_B
|
| gptkbp:UNII |
J3M7L9675F
|
| gptkbp:usedFor |
treatment of cervical dystonia
treatment of sialorrhea |
| gptkbp:bfsParent |
gptkb:Vesicle-associated_membrane_protein
gptkb:synaptobrevin |
| gptkbp:bfsLayer |
7
|